metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Impact of viral detection in patients with community-acquired pneumonia: An obse...
Journal Information
Vol. 161. Issue 12.
Pages 523-529 (December 2023)
Share
Share
Download PDF
More article options
Visits
5
Vol. 161. Issue 12.
Pages 523-529 (December 2023)
Original article
Impact of viral detection in patients with community-acquired pneumonia: An observational cohort study
Impacto de la detección viral en pacientes con neumonía comunitaria: estudio de cohortes observacional
Visits
5
Julia Sellarès-Nadala,b,c, Joaquin Burgosa,b,
Corresponding author
joaquin.burgos@vallhebron.cat

Corresponding author.
, Fernando Velasquezd, Maria Teresa Martin-Gómezd, Andrés Antónd, Dani Romero-Herrerad, Simeón Eremievb, Pau Bosch-Nicolaua,b, Dolors Rodriguez-Pardob, Oscar Lenb, Vicenç Falcóa,b
a Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Barcelona, Spain
b Infectious Diseases Department, Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona, Spain
c Malalties Infeccioses Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Barcelona, Spain
d Microbiology Department, Vall d’Hebron Hospital Universitari, Barcelona, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (6)
Table 1. Baseline and microbiological characteristics of the study population and differences in patients with and without viral infection.
Table 2. Microbiological procedures performed according to the time of the year.
Table 3. Bacterial pathogens documented in patients with and without viral infection.
Table 4. Detailed microbiological information.
Table 5. Clinical characteristics and outcomes of patients with and without viral infection.
Table 6. Risk factors for respiratory failure and ICU admission. Multivariate analysis.
Show moreShow less
Abstract
Purpose

The presence of a respiratory virus in patients with community-acquired pneumonia (CAP) may have an impact on the bacterial etiology and clinical presentation. In this study we aimed to assess the role of viral infection in the bacterial etiology and outcomes of patients with CAP.

Methods

We performed a retrospective study of all adults hospitalized with CAP between November 2017 and October 2018. Patients were classified according to the presence of viral infection. An unvaried and a multivaried analysis were performed to identify variables associated with viral infection and clinical outcomes.

Results

Overall 590 patients were included. A microorganism was documented in 375 cases (63.5%). A viral infection was demonstrated in 118 (20%). The main pathogens were Streptococcus pneumoniae (35.8%), Staphylococcus aureus (2.9%) and influenza virus (10.8%). A trend to a higher rate of S. aureus (p=0.06) in patients with viral infection was observed. Patients with viral infection had more often bilateral consolidation patterns (17.8% vs 10.8%, p=0.04), respiratory failure (59.3% vs 42.8%, p=0.001), ICU admission (17.8% vs 7%, p=0.001) and invasive mechanical ventilation (9.3% vs 2.8%, p=0.003). Risk factors for respiratory failure were chronic lung disease, age >65 years, positive blood cultures and viral infection. Influenza, virus but no other respiratory viruses, was associated with respiratory failure (OR, 3.72; 95% CI, 2.06–6.73).

Conclusions

Our study reinforces the idea that co-viral infection has an impact in the clinical presentation of CAP causing a more severe clinical picture. This impact seems to be mainly due to influenza virus infection.

Keywords:
Pneumonia
Influenza
Virology
Staphylococcus aureus
Respiratory failure
Resumen
Objetivos

La presencia de virus respiratorios en pacientes con neumonía adquirida en la comunidad (NAC) puede tener un impacto en la etiología bacteriana y en la presentación clínica. El objetivo de este estudio fue evaluar el papel de la infección viral en la etiología bacteriana y la evolución de los pacientes con NAC.

Métodos

Realizamos un estudio retrospectivo de todos los adultos hospitalizados con diagnóstico de NAC entre noviembre de 2017 y octubre de 2018. Los pacientes fueron clasificados según la presencia de infección viral. Se realizó un análisis univariado y multivariado para identificar variables asociadas con la infección viral y la evolución clínica.

Resultados

En total se incluyeron 590 pacientes. Se documentó el microorganismo en 375 casos (63,5%). Se demostró una infección viral en 118 (20%). Los principales patógenos fueron S. pneumoniae (35,8%), S. aureus (2,9%) y virus de la influenza (10,8%). Se observó una tendencia a una mayor tasa de S. aureus (p=0,06) en pacientes con infección viral. Los pacientes con infección viral tenían con mayor frecuencia patrones de consolidación bilateral (17,8% vs 10,8%; p=0,04), insuficiencia respiratoria (59,3% vs 42,8%; p=0,001), ingreso en UCI (17,8% vs 7%; p=0,001) y necesidad de ventilación mecánica invasiva (9,3% vs 2,8%; p=0,003). Los factores de riesgo para insuficiencia respiratoria fueron enfermedad pulmonar crónica, edad >65 años, hemocultivos positivos e infección viral. El virus de la influenza, pero ningún otro virus respiratorio, se asoció con insuficiencia respiratoria (OR: 3,72; IC 95%: 2,06-6,73).

Conclusiones

Nuestro estudio refuerza la idea de que la infección viral tiene un impacto en la presentación clínica de la NAC provocando un cuadro clínico más grave. Este impacto parece deberse principalmente a la infección por el virus de la influenza.

Palabras clave:
Neumonía
Influenza
Virología
Staphylococcus aureus
Insuficiencia respiratoria

Article

These are the options to access the full texts of the publication Medicina Clínica
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos